These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays. Nandakumar V; Profaizer T; Lozier BK; Elgort MG; Larragoite ET; Williams ESCP; Solis-Leal A; Lopez JB; Berges BK; Planelles V; Rychert J; Slev PR; Delgado JC Arch Pathol Lab Med; 2021 Oct; 145(10):1212-1220. PubMed ID: 34181714 [TBL] [Abstract][Full Text] [Related]
9. Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants. Morinaga Y; Tani H; Terasaki Y; Nomura S; Kawasuji H; Shimada T; Igarashi E; Saga Y; Yoshida Y; Yasukochi R; Kaneda M; Murai Y; Ueno A; Miyajima Y; Fukui Y; Nagaoka K; Ono C; Matsuura Y; Fujimura T; Ishida Y; Oishi K; Yamamoto Y Microbiol Spectr; 2021 Dec; 9(3):e0056021. PubMed ID: 34851163 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies. James J; Rhodes S; Ross CS; Skinner P; Smith SP; Shipley R; Warren CJ; Goharriz H; McElhinney LM; Temperton N; Wright E; Fooks AR; Clark TW; Brookes SM; Brown IH; Banyard AC Viruses; 2021 Apr; 13(4):. PubMed ID: 33924168 [TBL] [Abstract][Full Text] [Related]
11. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19. Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T; Front Public Health; 2020; 8():620222. PubMed ID: 33681115 [No Abstract] [Full Text] [Related]
12. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls. Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Clinical Performance of 7 Serological Assays for SARS-CoV-2 for Use in Clinical Laboratories. Plaga A; Wei R; Olson E; Payto D; Harrington J; Nwe-Kissig PT; Strizzi M; Zilka S; Ko J; Colón-Franco JM J Appl Lab Med; 2021 Jul; 6(4):998-1004. PubMed ID: 33825844 [TBL] [Abstract][Full Text] [Related]
14. A Multiplex Microsphere IgG Assay for SARS-CoV-2 Using ACE2-Mediated Inhibition as a Surrogate for Neutralization. Cameron A; Porterfield CA; Byron LD; Wang J; Pearson Z; Bohrhunter JL; Cardillo AB; Ryan-Muntz L; Sorensen RA; Caserta MT; Angeloni S; Hardy DJ; Zand MS; Pecora ND J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139422 [TBL] [Abstract][Full Text] [Related]
15. Multiplex assessment of SARS-CoV-2 antibodies improves assay sensitivity and correlation with neutralizing antibodies. Cook N; Xu L; Hegazy S; Wheeler BJ; Anderson AR; Critelli N; Yost M; McElroy AK; Shurin MR; Wheeler SE Clin Biochem; 2021 Nov; 97():54-61. PubMed ID: 34453893 [TBL] [Abstract][Full Text] [Related]